Strides Arcolab Limited (STAR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Date: July 21, 2014
Pages: 50
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: S9A689EC785EN
Leaflet:

Download PDF Leaflet

Strides Arcolab Limited (STAR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Summary

Strides Arcolab Limited (Strides Arcolab) is a pharmaceutical company. The company operates through a single segment Pharmaceuticals, its business activities are classified into two product divisions, Pharmaceutical Generics and Specialty. It runs development and manufacture of IP-led niche products, in particular sterile injectables. Strides Arcolab is a manufacturer of soft gelatin capsules. Strides Arcolab’s product categories across Agila include Penems, Penicillins, Cephalosporins, Ophthalmics, Peptides, and Controlled Substances. The company delivers packaging formats including vials liquid and dry powder, pre filled syringes (PFS), suspension injections, ampoules, and lyophilized forms. It gains access to high expression mammalian and microbial platform-based development capabilities. Arcolab is headquartered in Bangalore, Karnataka, India.

Strides Arcolab Limited (STAR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements - The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy - The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company.
Strides Arcolab Limited, Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Strides Arcolab Limited, Pharmaceuticals & Healthcare Deals By Type, 2008 to YTD 2014
Strides Arcolab Limited, Pharmaceuticals & Healthcare, Deals By Region, 2008 to YTD 2014
Strides Arcolab Limited, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2008 to YTD 2014
Strides Arcolab Limited, Medical Devices Deals, 2008 to YTD 2014
Strides Arcolab Limited, Pharmaceuticals & Healthcare, Deals Summary, 2008 to YTD 2014
Strides Arcolab Limited, Pharmaceuticals & Healthcare, Deal Details
Asset Purchase
Strides Arcolab Acquires Sterile Drugs Manufacturing Facility From Star Drugs and Research Labs For US$23.5 Million
Strides Acquires Brazilian Manufacturing Facility From Aspen Pharmacare
Partnerships
Strides Arcolab Forms Joint Venture With Bio-XCell
Strides Arcolab Enters Into Joint Venture Agreement With BioChimico
Pfizer Enters Into Co-Marketing Agreement With Strides Arcolab
Licensing Agreements
Strides Arcolab Enters Into Licensing Agreement With Eli Lilly For Generic Cancer Medicines
Strides Arcolab Enters Into Licensing Agreement With Gilead Sciences For Generic Versions Of Emtricitabine
Gilead Sciences Extends Licensing Agreement With Strides Arcolab For Tenofovir, Elvitegravir, Cobicistat And Quad
Strides Arcolab Enters Into Licensing Agreement With Pfizer
Onco Therapies Enters Into Licensing Agreement With GlaxoSmithKline
Equity Offering
Strides Arcolab Invests in Oncobiologics
Strides Arcolab Completes Private Placement Of US$100 Million
Strides Arcolab Completes Private Placement Of Equity Shares For US$1 Million
Acquisition
Mylan Completes Acquisition Of Agila Specialties From Strides Arcolab For Up To US$1.75 Billion
PROPARCO Acquires 20% Stake In Strides Africa From Strides Arcolab For US$13 Million
Watson Pharma Acquires Ascent Pharmahealth From Strides Arcolab And Dennis Bastas For US$394 Million
Strides Arcolab Completes Acquisition Of Additional 33.7% Stake In Ascent Pharmahealth For US$33 Million
Strides Arcolab Acquires 70% Stake In Inbiopro Solutions
Ascent Pharmahealth Acquires Green Cross Pharma
Strides Acquires 50% Stake In Onco Therapies And Onco Labs From Aspen
Strides Arcolab Acquires 55.5% Stake In Ascent Pharmahealth
Strides Arcolab Acquires An Additional Stake In Grandix Pharma
P I Drugs & Pharma Acquires Majority Interest In Strides Italia From Strides Arcolab
Genepharm Acquires Ascent Pharmahealth From Strides Arcolab
Strides Arcolab Limited - Key Competitors
Key Employees
Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Strides Arcolab Limited, Pharmaceuticals & Healthcare, Key Facts, 2014
Strides Arcolab Limited, Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Strides Arcolab Limited, Pharmaceuticals & Healthcare, Deals By Region, 2008 to YTD 2014
Strides Arcolab Limited, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2008 to YTD 2014
Strides Arcolab Limited, Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Strides Arcolab Limited, Pharmaceuticals & Healthcare Deals By Type, 2008 to YTD 2014
Strides Arcolab Limited, Pharmaceuticals & Healthcare, Deals By Region, 2008 to YTD 2014
Strides Arcolab Limited, Deals By Therapy Area, 2008 to YTD 2014
Strides Arcolab Limited, Medical Devices Deals, 2008 to YTD 2014
Strides Arcolab Limited, Pharmaceuticals & Healthcare, Deals Summary, 2008 to YTD 2014
Strides Arcolab Acquires Sterile Drugs Manufacturing Facility From Star Drugs and Research Labs For US$23.5 Million
Strides Acquires Brazilian Manufacturing Facility From Aspen Pharmacare
Strides Arcolab Forms Joint Venture With Bio-XCell
Strides Arcolab Enters Into Joint Venture Agreement With BioChimico
Pfizer Enters Into Co-Marketing Agreement With Strides Arcolab
Strides Arcolab Enters Into Licensing Agreement With Eli Lilly For Generic Cancer Medicines
Strides Arcolab Enters Into Licensing Agreement With Gilead Sciences For Generic Versions Of Emtricitabine
Gilead Sciences Extends Licensing Agreement With Strides Arcolab For Tenofovir, Elvitegravir, Cobicistat And Quad
Strides Arcolab Enters Into Licensing Agreement With Pfizer
Onco Therapies Enters Into Licensing Agreement With GlaxoSmithKline
Strides Arcolab Invests in Oncobiologics
Strides Arcolab Completes Private Placement Of US$100 Million
Strides Arcolab Completes Private Placement Of Equity Shares For US$1 Million
Mylan Completes Acquisition Of Agila Specialties From Strides Arcolab For Up To US$1.75 Billion
PROPARCO Acquires 20% Stake In Strides Africa From Strides Arcolab For US$13 Million
Watson Pharma Acquires Ascent Pharmahealth From Strides Arcolab And Dennis Bastas For US$394 Million
Strides Arcolab Completes Acquisition Of Additional 33.7% Stake In Ascent Pharmahealth For US$33 Million
Strides Arcolab Acquires 70% Stake In Inbiopro Solutions
Ascent Pharmahealth Acquires Green Cross Pharma
Strides Acquires 50% Stake In Onco Therapies And Onco Labs From Aspen
Strides Arcolab Acquires 55.5% Stake In Ascent Pharmahealth
Strides Arcolab Acquires An Additional Stake In Grandix Pharma
P I Drugs & Pharma Acquires Majority Interest In Strides Italia From Strides Arcolab
Genepharm Acquires Ascent Pharmahealth From Strides Arcolab
Strides Arcolab Limited, Key Competitors
Strides Arcolab Limited, Key Employees
Strides Arcolab Limited, Subsidiaries

LIST OF FIGURES

Strides Arcolab Limited, Pharmaceuticals & Healthcare, Deals by Type, 2008 to YTD 2014
Strides Arcolab Limited, Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Strides Arcolab Limited, Pharmaceuticals & Healthcare, Deals by Type, 2008 to YTD 2014
Strides Arcolab Limited, Pharmaceuticals & Healthcare, Deals By Region, 2008 to YTD 2014
Strides Arcolab Limited, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2008 to YTD 2014
Strides Arcolab Limited, Medical Devices Deals, 2008 to YTD 2014
Skip to top


Ask Your Question

Strides Arcolab Limited (STAR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: